vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and RANGE RESOURCES CORP (RRC). Click either name above to swap in a different company.
RANGE RESOURCES CORP is the larger business by last-quarter revenue ($786.9M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). RANGE RESOURCES CORP runs the higher net margin — 22.8% vs 6.8%, a 15.9% gap on every dollar of revenue. On growth, RANGE RESOURCES CORP posted the faster year-over-year revenue change (18.0% vs -1.7%). Over the past eight quarters, RANGE RESOURCES CORP's revenue compounded faster (14.6% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Range Resources Corporation is a natural gas exploration and production company, the headquartered is in Fort Worth, Texas. It operates in the Marcellus Formation, where it is the largest land owners.
MD vs RRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $786.9M |
| Net Profit | $33.7M | $179.1M |
| Gross Margin | — | 94.5% |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 22.8% |
| Revenue YoY | -1.7% | 18.0% |
| Net Profit YoY | 10.5% | 88.8% |
| EPS (diluted) | $0.40 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $786.9M | ||
| Q3 25 | $492.9M | $655.3M | ||
| Q2 25 | $468.8M | $699.6M | ||
| Q1 25 | $458.4M | $846.3M | ||
| Q4 24 | $502.4M | $667.0M | ||
| Q3 24 | $511.2M | $567.9M | ||
| Q2 24 | $504.3M | $513.2M | ||
| Q1 24 | $495.1M | $598.8M |
| Q4 25 | $33.7M | $179.1M | ||
| Q3 25 | $71.7M | $144.3M | ||
| Q2 25 | $39.3M | $237.6M | ||
| Q1 25 | $20.7M | $97.1M | ||
| Q4 24 | $30.5M | $94.8M | ||
| Q3 24 | $19.4M | $50.7M | ||
| Q2 24 | $-153.0M | $28.7M | ||
| Q1 24 | $4.0M | $92.1M |
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | -31.3% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | 6.8% | 22.8% | ||
| Q3 25 | 14.5% | 22.0% | ||
| Q2 25 | 8.4% | 34.0% | ||
| Q1 25 | 4.5% | 11.5% | ||
| Q4 24 | 6.1% | 14.2% | ||
| Q3 24 | 3.8% | 8.9% | ||
| Q2 24 | -30.3% | 5.6% | ||
| Q1 24 | 0.8% | 15.4% |
| Q4 25 | $0.40 | $0.75 | ||
| Q3 25 | $0.84 | $0.60 | ||
| Q2 25 | $0.46 | $0.99 | ||
| Q1 25 | $0.24 | $0.40 | ||
| Q4 24 | $0.37 | $0.38 | ||
| Q3 24 | $0.23 | $0.21 | ||
| Q2 24 | $-1.84 | $0.12 | ||
| Q1 24 | $0.05 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $204.0K |
| Total DebtLower is stronger | $570.5M | $1.2B |
| Stockholders' EquityBook value | $865.9M | $4.3B |
| Total Assets | $2.2B | $7.4B |
| Debt / EquityLower = less leverage | 0.66× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $204.0K | ||
| Q3 25 | $340.1M | $175.0K | ||
| Q2 25 | $224.7M | $134.0K | ||
| Q1 25 | $99.0M | $344.6M | ||
| Q4 24 | $229.9M | $304.5M | ||
| Q3 24 | $103.8M | $277.4M | ||
| Q2 24 | $19.4M | $251.1M | ||
| Q1 24 | $8.0M | $343.1M |
| Q4 25 | $570.5M | $1.2B | ||
| Q3 25 | $577.2M | $1.2B | ||
| Q2 25 | $583.9M | $1.2B | ||
| Q1 25 | $590.5M | $1.7B | ||
| Q4 24 | $597.1M | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | $865.9M | $4.3B | ||
| Q3 25 | $890.7M | $4.2B | ||
| Q2 25 | $833.8M | $4.1B | ||
| Q1 25 | $789.2M | $3.9B | ||
| Q4 24 | $764.9M | $3.9B | ||
| Q3 24 | $732.5M | $3.9B | ||
| Q2 24 | $706.5M | $3.9B | ||
| Q1 24 | $856.2M | $3.8B |
| Q4 25 | $2.2B | $7.4B | ||
| Q3 25 | $2.2B | $7.2B | ||
| Q2 25 | $2.1B | $7.1B | ||
| Q1 25 | $2.0B | $7.4B | ||
| Q4 24 | $2.2B | $7.3B | ||
| Q3 24 | $2.1B | $7.2B | ||
| Q2 24 | $2.0B | $7.3B | ||
| Q1 24 | $2.2B | $7.4B |
| Q4 25 | 0.66× | 0.28× | ||
| Q3 25 | 0.65× | 0.29× | ||
| Q2 25 | 0.70× | 0.29× | ||
| Q1 25 | 0.75× | 0.43× | ||
| Q4 24 | 0.78× | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $257.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $257.5M | ||
| Q3 25 | $137.3M | $247.5M | ||
| Q2 25 | $137.2M | $336.2M | ||
| Q1 25 | $-117.5M | $330.1M | ||
| Q4 24 | $133.0M | $217.9M | ||
| Q3 24 | $91.8M | $245.9M | ||
| Q2 24 | $107.0M | $148.8M | ||
| Q1 24 | $-125.2M | $331.9M |
| Q4 25 | 3.39× | 1.44× | ||
| Q3 25 | 1.91× | 1.72× | ||
| Q2 25 | 3.49× | 1.42× | ||
| Q1 25 | -5.66× | 3.40× | ||
| Q4 24 | 4.36× | 2.30× | ||
| Q3 24 | 4.72× | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | -31.03× | 3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
